A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00768131
Recruitment Status : Withdrawn
First Posted : October 7, 2008
Last Update Posted : October 28, 2015
ImClone LLC
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : October 2008
  Actual Study Completion Date : October 2008